Metraipolis › archive › dc_a353fbbb7425

Transglutaminase 2 exacerbates ovarian cancer survival by directly inactivating GSK3β — Europe PMC PMID:41629270

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41629270
DOI
10.1038/s41419-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-06T07:48:10.262Z
SHA-256 of the archived text
67f851dfd58cb1fd6754ef18ac47d78e9c520b92d9a39380968aba66c0fcf350
Stable URL of this page
https://metraipolis.com/documento/dc_a353fbbb7425

How to cite

Transglutaminase 2 exacerbates ovarian cancer survival by directly inactivating GSK3β — Europe PMC PMID:41629270 — Europe PMC (en), https://europepmc.org/article/MED/41629270 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a353fbbb7425 (Metraipolis archive dc_a353fbbb7425, sha256 67f851dfd58cb1fd6754ef18ac47d78e9c520b92d9a39380968aba66c0fcf350)
BibTeX
@misc{dca353fbbb7425,
  title = {Transglutaminase 2 exacerbates ovarian cancer survival by directly inactivating GSK3β — Europe PMC PMID:41629270},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41629270},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a353fbbb7425; sha256 67f851dfd58cb1fd6754ef18ac47d78e9c520b92d9a39380968aba66c0fcf350},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41629270. Agents can read the archived copy with the MCP tool read_document.